Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q2 2026 · 10-Q
Revenue$274.11M$274.11M−3.4% vs Q2 2025 Net Income$42.21M$42.21M−22.4% vs Q2 2025 EPS Diluted$0.86$0.86−21.1% vs Q2 2025 Gross Profit$151,579,000−3.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$57,486,000−17.6% Free Cash Flowderived$55,384,000−18.3% Margins · derivedGross margin55.3%−0.2 pt vs Q2 2025
Operating margin29.1%−0.7 pt vs Q2 2025
Net margin15.4%−3.8 pt vs Q2 2025
ended Sep 30, 2025 · filed Nov 6, 2025 · 37 d after period end